Showing results (781-790 of 2,106) with videos related to

Sort By:
Pageof 211
CNS Drugs|December 29, 2019
Long-Term Safety and Efficacy of Blonanserin Transdermal Patches in Japanese Patients with Schizophrenia: A 52-Week Open-Label, Multicenter StudyNakao Iwata, Jun Ishigooka, Ichiro Naoi, et al.
CNS Drugs|December 18, 2019
Prescription of Valproate-Containing Medicines in Women of Childbearing Potential who have Psychiatric Disorders: Is It Worth the Risk?David S Baldwin, Hugo J F Amaro
CNS Drugs|March 19, 2020
Pharmacological Treatment of Methamphetamine/Amphetamine Dependence: A Systematic ReviewKrista J Siefried, Liam S Acheson, Nicholas Lintzeris, et al.
CNS Drugs|March 21, 2020
Fingolimod and Dimethyl-Fumarate-Derived Lymphopenia is not Associated with Short-Term Treatment Response and Risk of Infections in a Real-Life MS PopulationGiacomo Boffa, Nicolò Bruschi, Maria Cellerino, et al.
CNS Drugs|March 1, 2020
Sleep Disorders in Children and Adolescents with Autism Spectrum Disorder: Diagnosis, Epidemiology, and ManagementSamuele Cortese, Fang Wang, Marco Angriman, et al.
CNS Drugs|February 14, 2020
Management of Dementia-Related Psychosis, Agitation and Aggression: A Review of the Pharmacology and Clinical Effects of Potential Drug CandidatesMonika Marcinkowska, Joanna Śniecikowska, Nikola Fajkis, et al.
CNS Drugs|January 31, 2020
Pharmacotherapy for Cluster HeadacheRoemer B Brandt, Patty G G Doesborg, Joost Haan, et al.
CNS Drugs|December 5, 2018
Revisiting the Concept of Subjective Tolerability to Antipsychotic Medications in Schizophrenia and its Clinical and Research Implications: 30 Years LaterA George Awad
CNS Drugs|March 29, 2020
Adherence to Oral Antipsychotics Measured by Electronic Adherence Monitoring in Schizophrenia: A Systematic Review and Meta-analysisHodaka Yaegashi, So Kirino, Gary Remington, et al.
CNS Drugs|March 30, 2020
Changes in Anti-JCV Antibody Status in a Large Population of Multiple Sclerosis Patients Treated with NatalizumabEleonora Sgarlata, Clara Grazia Chisari, Emanuele D'Amico, et al.
Pageof 211